Search Results - "Bacharaki, D."

Outcomes of newly diagnosed myeloma patients requiring dialysis: renal recovery, importance of rapid response and survival benefit by Dimopoulos, M A, Roussou, M, Gavriatopoulou, M, Fotiou, D, Ziogas, D C, Migkou, M, Panagiotidis, I, Eleutherakis-Papaiakovou, E, Kanellias, N, Psimenou, E, Marinaki, S, Bacharaki, D, Mparmparoussi, D, Matsouka, C, Giannouli, S, Terpos, E, Kastritis, E

Get full text

1C.09: SERUM RESISTIN AS AN INDEPENDENT BIOMARKER ASSOCIATED WITH ALL-CAUSE AND CARDIOVASCULAR MORTALITY IN ELDERLY HYPERTENSIVE, NON-DIABETIC PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) by Vlahakos, D.V, Dalamaga, M, Marouga, A, Bacharaki, D, Drakou, A, Dimas, C

“…OBJECTIVE:Hypertensive patients with CKD present an increased risk for cardiovascular mortality. Among the proteins synthesized and released from adipose…”
Get full text

Anemia due to coadministration of renin-angiotensin-system inhibitors and PPARγ agonists in uncomplicated diabetic patients by Raptis, A E, Bacharaki, D, Mazioti, M, Marathias, K P, Markakis, K P, Raptis, S A, Dimitriadis, G D, Vlahakos, D V

“…Therapy with either angiotensin converting enzyme inhibitors and angiotensin receptor blockers (ACEI/ARB) or thiazolidinediones (TZD) is associated with…”
Get more information

Hypertension in chronic hemodialysis patients: current view on pathophysiology and treatment by Grekas, D, Bamichas, G, Bacharaki, D, Goutzaridis, N, Kasimatis, E, Tourkantonis, A

“…Hypertension accounts for 65 - 85% of patients beginning dialysis, and dialysis alone controls hypertension in over 50% of patients. We have surveyed the…”
Get more information

Combined treatment with low-dose pravastatin and fish oil in post-renal transplantation dislipidemia by Grekas, D, Kassimatis, E, Makedou, A, Bacharaki, D, Bamichas, G, Tourkantonis, A

“…The most common cause of post-transplant dyslipidemia is the use of corticosteroids and cyclosporin-A (CyA). The HMG-CoA reductase inhibitors have emerged as…”
Get more information

Plasma endothelin in cyclosporine A–treated renal transplant patients by Grekas, D, Bamichas, G, Karamouzis, M, Bacharaki, D, Savidis, N, Tourkantonis, A

Get full text

USEFULNESS OF LOW DOSE THRICE WEEKLY ADMINISTRATION OF SPIRONOLACTONE IN PATIENTS WITH OR WITHOUT CHRONIC KIDNEY DISEASE AND RESISTANT HYPERTENSION: PP.8.217 by Mazioti, M., Raptis, A., Drakou, A., Bacharaki, D., Vlahakos, D.

Get full text

The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis by Thodis, E, Passadakis, P, Panagoutsos, S, Bacharaki, D, Euthimiadou, A, Vargemezis, V

“…The objective of this study was to evaluate the effectiveness of mupirocin on Staphylococcus aureus with regard to peritoneal dialysis (PD)-catheter exit-site…”
Get full text